Concepedia

LBA7 Nivolumab plus gemcitabine-cisplatin versus gemcitabine-cisplatin alone for previously untreated unresectable or metastatic urothelial carcinoma: Results from the phase III CheckMate 901 trial

Michiel S. van der Heijden, Guru Sonpavde, Thomas Powles, Andrea Necchi, Mauricio Burotto, Michael Schenker, J. P. Sade, Aristotelis Bamias, Philippe Beuzeboc, Jens Bedke,

Annals of Oncology · 2023 · 14 citations · 0 references

Open access

Concepts

MedicineOncologyPharmacologyChemotherapyMetastasisUrologic OncologyBladder CancerCancer ImmunotherapyMetastatic Cancer ManagementMetastatic Disease TreatmentMetastatic Urologic CancerUrothelial CarcinomaGemcitabine-based TherapyMetastatic Bladder CancerMetastatic Urothelial Carcinoma ImmunotherapyUrothelial Carcinoma Adjuvant TherapyUrothelial Carcinoma Systemic Therapy